4-Oxo-3-phenyl-3,4-dihydro-benzo[d][1,2,3]triazine-7-carboxylic acid amide

ID: ALA36209

PubChem CID: 9993059

Max Phase: Preclinical

Molecular Formula: C14H10N4O2

Molecular Weight: 266.26

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)c1ccc2c(=O)n(-c3ccccc3)nnc2c1

Standard InChI:  InChI=1S/C14H10N4O2/c15-13(19)9-6-7-11-12(8-9)16-17-18(14(11)20)10-4-2-1-3-5-10/h1-8H,(H2,15,19)

Standard InChI Key:  UBZAINQHXGXCLB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    2.3042   -2.2292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3042   -1.4042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5917   -2.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8750   -2.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5917   -0.9875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8792   -1.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2625   -0.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1625   -2.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5500   -1.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1625   -0.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0167   -2.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5875   -3.4667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5500   -2.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2625   -0.1667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9833   -1.4042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0167   -3.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7292   -2.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4417   -2.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7292   -3.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4417   -3.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  3  1  0
  5  2  2  0
  6  4  1  0
  7  9  1  0
  8  4  2  0
  9 13  2  0
 10  6  2  0
 11  1  1  0
 12  3  2  0
 13  8  1  0
 14  7  2  0
 15  7  1  0
 16 11  2  0
 17 11  1  0
 18 17  2  0
 19 16  1  0
 20 18  1  0
  5  6  1  0
 19 20  2  0
  9 10  1  0
M  END

Alternative Forms

Associated Targets(non-human)

TLX-5 (157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 266.26Molecular Weight (Monoisotopic): 266.0804AlogP: 0.88#Rotatable Bonds: 2
Polar Surface Area: 90.87Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.13CX Basic pKa: CX LogP: 2.52CX LogD: 2.52
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.74Np Likeness Score: -1.82

References

1. Clark AS, Deans B, Stevens MF, Tisdale MJ, Wheelhouse RT, Denny BJ, Hartley JA..  (1995)  Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomide.,  38  (9): [PMID:7739008] [10.1021/jm00009a010]

Source